Cannabis Cannabinoids Explained: THC, CBD, CBG, CBN & More
Last updated: August 2026
Quick answer: Cannabinoids are a family of compounds that interact with biological targets in the body. Cannabis makes phytocannabinoids such as THCA, CBDA and CBGA; the body makes endocannabinoids such as anandamide and 2-AG; laboratories can make synthetic cannabinoids. THC can intoxicate. CBD generally does not, but it is not risk-free. Minor cannabinoids such as CBG, CBN and CBC are interesting, but most product claims are ahead of the human evidence.
The three cannabinoid groups
| Group | Where it comes from | Examples |
|---|---|---|
| Phytocannabinoids | Made by plants, especially in cannabis glandular trichomes | THCA, THC, CBDA, CBD, CBGA, CBG, CBC and CBN |
| Endocannabinoids | Made on demand by the human and animal body | Anandamide (AEA) and 2-AG |
| Synthetic cannabinoids | Made in a laboratory | Some research or prescription compounds, plus dangerous unregulated products sold as K2 or Spice |
The correct word is phytocannabinoid, not “photo-cannabinoid.” Also, “synthetic” does not describe one predictable product. An approved medicine and an unknown chemical sprayed onto plant material are not interchangeable just because both were made in a lab.
How cannabis makes cannabinoids
Think of a mature resin gland as a tiny chemical factory with a storage bubble on top. Cannabis builds and stores most of its cannabinoids in glandular trichomes concentrated on female flowers. CBGA acts as an important branch-point precursor that plant enzymes can turn into THCA, CBDA or CBCA.
Fresh flower contains mostly acidic cannabinoids: THCA rather than large amounts of THC, and CBDA rather than large amounts of CBD. Heat removes a carboxyl group in a process called decarboxylation, converting THCA to THC and CBDA to CBD. Time, light, oxygen and storage conditions can cause additional changes. That is one reason fresh flower, cured flower and a heated product do not have identical profiles.
Important: visible frost tells you that resin glands are present. It does not give you a THC percentage, identify every cannabinoid or prove potency. For that, you need a representative sample tested by a qualified laboratory.
Common cannabis cannabinoids, without the hype
| Compound | Plain-English role | What not to assume |
|---|---|---|
| THCA | The major acidic precursor to delta-9 THC in many drug-type cannabis plants | Raw THCA and heated THC are not pharmacologically identical |
| Delta-9 THC | The main intoxicating cannabinoid in cannabis; it activates CB1 receptors and can impair memory, coordination and judgment | A higher percentage does not automatically mean a better product or the same experience for every person |
| CBDA | The acidic precursor to CBD | Research on isolated compounds does not validate every raw-flower or supplement claim |
| CBD | Usually described as non-intoxicating and pharmacologically different from THC | “No high” does not mean no side effects, drug interactions or quality problems |
| CBGA / CBG | CBGA is a biosynthetic starting point for several major cannabinoid branches; CBG is its neutral form | Promising laboratory research is not the same as an approved cancer or disease treatment |
| CBN | A minor cannabinoid that can increase as THC oxidizes during aging and storage | An amber trichome is not a direct CBN meter, and CBN product claims are not guaranteed effects |
| CBC | A minor phytocannabinoid with early-stage pharmacology research | Limited human evidence cannot support broad medical promises |
For a closer look at CBD, use the separate CBD guide. Delta-8, delta-9, delta-10 and THC-O raise different chemistry and safety questions, so they remain a distinct THC-variants guide.
What the endocannabinoid system actually means
The endocannabinoid system includes signaling molecules such as anandamide and 2-AG, receptors including CB1 and CB2, and enzymes that make and break those signals down. It helps modulate several processes, but that does not mean every cannabinoid “balances” the whole body or treats every process connected to those receptors.
Delta-9 THC can activate CB1 receptors because its shape and chemistry let it interact with part of this signaling system. CBD is more complicated and does not act like a simple CB1 switch. Product dose, route, other compounds, tolerance and the individual all change the outcome.
Watch: why the cannabinoid number is not the whole profile
This short HWGrow comparison focuses on aroma—not medical effects or cannabinoid potency. It shows why three flowers can look similarly resinous but smell completely different. A THC number is one data point; the terpene and volatile profile, dose and the person still matter.
Video chapters
- 0:02 — Blueberry candy and fruit notes
- 0:21 — A very different savory profile
- 1:10 — Finding profiles through phenotype hunts
What the evidence can—and cannot—say
The FDA has approved one purified CBD drug, Epidiolex, for specific seizure disorders under medical supervision. That does not make an untested CBD gummy, flower or oil equivalent to the prescription product. CBD can interact with medications and has documented safety risks, including potential liver injury.
Human evidence for many minor cannabinoids is still limited. A cell, animal or receptor study can justify more research, but it cannot prove that a retail CBG or CBN product prevents cancer, cures insomnia or treats another condition. The legacy version of this article made that leap; this rebuild removes it.
Illicit synthetic cannabinoids such as K2 or Spice are not “stronger weed.” Their contents can be unpredictable and have caused severe illness. Do not group them with regulated cannabis or approved cannabinoid medicines.
How growers should use cannabinoid information
- Start with documented genetics. A cultivar’s cannabinoid potential is genetic, while environment and harvest handling affect how that potential is expressed.
- Read the batch report. A result from another grower, phenotype or harvest is not your flower’s chemistry.
- Check acidic and neutral forms. A report listing THCA is not “missing THC”; total-potential calculations account for conversion and molecular-weight loss.
- Do not shop by THC alone. Compare the full cannabinoid profile, aroma, contaminants, dose and your own response.
- Protect the finished flower. Heat, light, oxygen and poor storage can change cannabinoids and volatile compounds.
The harvest guide explains how to inspect flower maturity without pretending that a loupe is a potency test. If cannabinoid and aroma targets are part of a genetics project, Selfie Seeds™ is HWGrow’s in-house source for documented selections; each phenotype still needs its own observations and, when the number matters, its own lab result.
Useful tools—not potency shortcuts
Related HWGrow guides: Connect the chemistry to real-world questions with why people use cannabis, what at-home THC testers can and cannot tell you, and how THC absorption differs by consumption method.
A lab result and a personal experience are not the same measurement. Use the personal bud-quality scorecard for consistent aroma, flavor and effect notes.
Affiliate disclosure: Selfie Seeds™ is HWGrow’s in-house genetics source. HWGrow may earn a commission from qualifying Amazon purchases at no additional cost to you. Product categories can be replaced with equivalent items.
Cannabinoid FAQ
Are cannabinoids and terpenes the same?
No. They are different chemical families. They can occur in the same resin and both contribute to the complete profile, but THC, CBD and CBG are cannabinoids; myrcene, limonene and pinene are terpenes.
Does more visible frost mean more THC?
Not reliably. Frost shows abundant resin glands, but appearance cannot identify the compounds inside or calculate potency. Use a representative laboratory test for a cannabinoid percentage.
Does CBD get you high?
CBD is generally considered non-intoxicating and does not act like delta-9 THC. It can still cause side effects and drug interactions, and retail CBD is not automatically equivalent to an FDA-approved prescription product.
Research and official references
- Cannabis glandular trichomes as metabolite factories
- The biosynthesis of cannabinoids
- Review of the endocannabinoid system
- FDA regulation of cannabis and cannabis-derived products
- FDA consumer update on CBD risks and evidence
- CDC cannabis FAQ, including synthetic cannabinoids
This article is educational and is not medical advice. Do not drive or operate machinery while impaired. If you use medications, are pregnant or nursing, or are treating a health condition, discuss cannabinoid products with a qualified clinician.








